35° Partly Cloudy

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Community Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ProKidney Corp. - Class A Ordinary Shares (NQ:PROK)

2.295 -0.065 (-2.77%)

Streaming Delayed Price Updated: 11:29 AM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ProKidney Corp. - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 06, 2026

From ProKidney

Via GlobeNewswire

ProKidney Corp (NASDAQ:PROK) Reports Q3 2025 Earnings and Clinical Progress ↗

November 10, 2025

ProKidney (PROK) reports Q3 2025 results, beating EPS estimates. Key updates include strong Phase 3 trial enrollment and a confirmed FDA accelerated approval pathway for its kidney disease therapy.

Via Chartmill

Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern

November 10, 2025

San Diego, CA – November 10, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a dramatic collapse in its stock price, shedding nearly 50% of its value following the announcement of mixed results...

Via MarketMinute

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

November 10, 2025

From ProKidney

Via GlobeNewswire

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

November 06, 2025

From ProKidney

Via GlobeNewswire

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

October 29, 2025

From ProKidney

Via GlobeNewswire

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025

October 20, 2025

From ProKidney

Via GlobeNewswire

SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC ↗

October 02, 2025

Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.

Via Benzinga

Which stocks are experiencing notable movement on Friday? ↗

September 12, 2025

Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

What's going on in today's session ↗

September 11, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 11, 2025

Via Benzinga

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

August 27, 2025

From ProKidney

Via GlobeNewswire

Prediction: Chamath Palihapitiya's $250 Million SPAC Could Create the Next Palantir for America's Energy Grid ↗

August 24, 2025

Chamath Palihapitiya is launching a $250 million SPAC, called American Exceptionalism Acquisition Corp.

Via The Motley Fool

Topics Artificial Intelligence Economy

Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14% ↗

August 19, 2025

Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the poor performance track record.

Via Benzinga

ProKidney Reports 78 Percent Gain in Q2 ↗

August 12, 2025

Via The Motley Fool

Topics Intellectual Property

ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss ↗

August 12, 2025

ProKidney Corp. (PROK) reports Q2 2025 results with unexpected revenue and a narrower loss than expected. FDA progress on rilparencel and Phase 3 trial updates highlight key milestones. Cash runway...

Via Chartmill

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

August 12, 2025

From ProKidney

Via GlobeNewswire

Meet the Biotech Stock That Rocketed 775% Higher ↗

July 22, 2025

Via The Motley Fool

This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy? ↗

July 17, 2025

Via The Motley Fool

Unusual volume stocks are being observed in Tuesday's session. ↗

July 15, 2025

The trading volume of these stocks is deviating from the norm in today's session.

Via Chartmill

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 15, 2025

Via Benzinga

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

July 15, 2025

From ProKidney

Via GlobeNewswire

These stocks are moving in today's session ↗

July 14, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 10, 2025

Via Benzinga

In today's session, these stocks are experiencing unusual volume. ↗

July 10, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

AZZ Posts Better-Than-Expected Earnings, Joins MP Materials, WK Kellogg And Other Big Stocks Moving Higher On Thursday ↗

July 10, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

July 10, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 10, 2025

Via Benzinga

Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket ↗

July 10, 2025

Via Benzinga

Which stocks are most active on Wednesday? ↗

July 09, 2025

Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.

Via Chartmill

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

ProKidney Corp. - Class A Ordinary Shares (NQ:PROK)

All News about ProKidney Corp. - Class A Ordinary Shares

Sections

Services